Search studies using keywords
1,851 Studies in the database containing data with -log p ≥ 0 (showing 281-300)
Pages: << 11 12 13 14 15 16 17 18 19 20 >>
No data sets (in No Studies) added to Browser
Identifier Name Phenotype(s) Total p-values Related citationsAdd data sets to Browser Related data
HGVST1570 plus GWAS of Ovarian cancer 
  • Ovarian cancer (Serious invasive)
  • Ovarian cancer (All invasive)
17
HGVST1571 plus GWAS of Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer 
  • Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer (Dominant model)
  • Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer (Recessive model)
  • Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer (Additive model)
7
HGVST1572 plus GWAS of Non-alcoholic fatty liver disease 
  • Non-alcoholic fatty liver disease
4
HGVST1573 plus GWAS of Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) 
  • Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
  • Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) (Modelling analysis)
  • Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) (5 degree of freedom test)
74
HGVST1574 plus GWAS of Uric acid levels 
  • Uric acid levels (Obese)
  • Uric acid levels
  • Uric acid levels (Non-obese)
6
HGVST1567 plus GWAS of Pulmonary function in asthmatics 
  • Pulmonary function in asthmatics (ppFEV1)
  • Pulmonary function in asthmatics (ppFVC)
4
HGVST1566 plus GWAS of epilepsy prognosis in a prospective cohort of newly treated epilepsy 
  • 12-month remission of seizures
0
HGVST1563 plus GWAS of Iron deficiency 
  • Iron status biomarkers (Total iorn-binding capacity)
  • Iron status biomarkers (Total iron-binding capacity)
  • Iron status biomarkers (Transferrin saturation)
  • Iron status biomarkers (Body iron)
  • Iron status biomarkers (Serum ferritin concentration)
  • Iron status biomarkers (Unsaturated iron-binding capacity)
  • Iron deficiency (Case-control)
10
HGVST1564 plus GWAS of Metabolite levels 
  • Metabolite levels (glycine/serine)
  • Metabolite levels (betaine)
  • Metabolite levels (glycine)
  • Metabolite levels (adrenate)
  • Metabolite levels (serine)
6
HGVST1565 plus GWAS of Age-related macular degeneration 
  • Age-related macular degeneration
  • Age-related macular degeneration (EA)
29
HGVST1555 plus GWAS of Lymphoma 
  • Lymphoma (LYM)
  • Lymphoma (NHL)
  • Lymphoma (FL)
13
HGVST1556 plus GWAS of Corneal astigmatism 
  • Corneal astigmatism
17
HGVST1557 plus GWAS of Osteoporosis 
  • Osteoporosis
1
HGVST1558 plus GWAS of Breast cancer 
  • Breast cancer (Meta P value)
  • Breast cancer (Pooled P value)
3
HGVST1559 plus GWAS of Alcohol dependence 
  • Alcohol dependence
1
HGVST1560 plus GWAS of Type 2 diabetes (dietary heme iron intake interaction) 
  • Type 2 diabetes (dietary heme iron intake interaction)
4
HGVST1561 plus GWAS of Colorectal cancer 
  • Colorectal cancer
3
HGVST1562 plus GWAS of Orofacial clefts (interaction) 
  • Orofacial clefts (interaction) (Maternal alcohol consumption, 1df)
2
HGVST1548 plus GWAS of Urinary symptoms in response to radiotherapy in prostate cancer 
  • Urinary symptoms in response to radiotherapy in prostate cancer (at 2-3 yrs)
1
HGVST1549 plus GWAS of Squamous cell carcinoma 
  • Squamous cell carcinoma
1